NCT06829368

Brief Summary

This study examines the impact of theta-burst transcranial focused ultrasound stimulation (tFUS) on cognitive performance in healthy participants, specifically focusing on both acute and post-stimulation effects on visual working memory (vWM). The investigation will compare TUS effects across targeted deep cortical and subcortical brain regions involved in cognitive processing. Neurophysiological changes following stimulation will be assessed using EEG, providing insight into tFUS-induced modulations in working memory-related brain activity.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2025

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

February 5, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 29, 2025

Status Verified

February 1, 2025

Enrollment Period

11 months

First QC Date

February 5, 2025

Last Update Submit

September 26, 2025

Conditions

Keywords

Transcranial Ultrasound StimulationTheta-Burst StimulationCognitive EnhancementVisual Working MemoryEEGMediodorsal ThalamusAnterior Cingulate CortexAnterior InsulaTranscranial Focused Ultrasound StimulationFocused Ultrasound StimulationLow-Intensity Focused Ultrasound Stimulation

Outcome Measures

Primary Outcomes (2)

  • Performance Change in Visual Working Memory Task

    Measuring behavioural change in the modified Object in Place Visual Working Memory task, assessed through accuracy and reaction time.

    Measured at three time points (pre-stimulation, on-stimulation, and post-stimulation) during each session. Each participant completes four sessions, occurring once per week over approximately 4 weeks.

  • EEG Changes Post Stimulation

    Analysis of EEG markers associated with cognitive processes

    Measured at three time points (pre-stimulation, on-stimulation, and post-stimulation) during each session. Each participant completes four sessions, occurring once per week over approximately 4 weeks.

Study Arms (4)

Mediodorsal Thalamus Stimulation

ACTIVE COMPARATOR

Theta-burst tFUS targeting the mediodorsal thalamus

Other: Transcranial Focused Ultrasound Stimulation

Dorsal Anterior Cingulate Cortex Stimulation

ACTIVE COMPARATOR

Theta-burst tFUS targeting the dorsal anterior cingulate cortex

Other: Transcranial Focused Ultrasound Stimulation

Anterior Insula Stimulation

ACTIVE COMPARATOR

Theta-burst tFUS targeting the anterior insula

Other: Transcranial Focused Ultrasound Stimulation

Lateral Ventricle Stimulation

SHAM COMPARATOR

Theta-burst tFUS targeting the lateral ventricle.

Other: Transcranial Focused Ultrasound Stimulation

Interventions

Using MRI neuronavigation, the investigators will implement theta-burst tFUS in one of the four targets.

Anterior Insula StimulationDorsal Anterior Cingulate Cortex StimulationLateral Ventricle StimulationMediodorsal Thalamus Stimulation

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18-55years
  • Healthy adults with no history of neurological or psychiatric disorders
  • Eligible to undergo a T1-weighted MRI scan for tFUS neuronavigational purposes
  • Ability to adhere to the tFUS study schedule and complete all assessments
  • Right-handed
  • Fluent in English
  • Abstinence from the use of any recreational drugs in the 48-hour period prior to taking part in the experiment.
  • Abstinence from consuming no more than 4 alcoholic units within the 24-hour period before participation.

You may not qualify if:

  • Any current psychiatric diagnosis
  • Neurodevelopmental disorders; history of central nervous system disease, concussion, or other neurological sequelae; presence of tumors, seizures, meningitis, encephalitis, or any abnormal MRI findings of the brain
  • Use of any psychotropic medications within five half-lives before the procedure
  • Presence of metal implants contraindicated for MRI
  • History of head trauma with loss of consciousness
  • Calcification in sonicated parts of the brain.
  • Visual impairments that cannot be corrected with glasses
  • Inability to complete cognitive testing requirements
  • Active participation or plans for enrollment in other clinical trials that may impact psychosocial functioning
  • History of repeated substance abuse or dependence (excluding nicotine and caffeine); use of medications such as stimulants, modafinil, thyroid medication, or steroids
  • No skin disease on or close to the scalp.
  • History of seizure or epilepsy; use of medications that lower seizure thresholds
  • Claustrophobia or any other condition precluding MRI assessment
  • Pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neuromodulation Lab, Medical School, Queen's Medical Centre

Nottingham, Nottinghamshire, NG7 2UH, United Kingdom

RECRUITING

Study Officials

  • Marcus Kaiser, Professor of Neuroinformatics

    University of Nottingham

    PRINCIPAL INVESTIGATOR
  • Mohammad Katshu, Clinical Associate Professor

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefanos A Kontogouris, PhD Student

CONTACT

Mohammad Alkhawashki, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The lateral ventricle is designated as the sham control site, given prior evidence that tFUS targeting this region elicits no detectable effects. This choice facilitates consistent participant expectations across sessions, enabling a reliable baseline comparison. To further reduce bias, participants are blinded to the specific brain region targeted in each session and unaware of whether the stimulation is active or sham. This methodological approach aims to prevent any performance adjustment based on presumed effects of the stimulation, thereby enhancing the validity of the results.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neuroinformatics

Study Record Dates

First Submitted

February 5, 2025

First Posted

February 17, 2025

Study Start

January 20, 2025

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

September 29, 2025

Record last verified: 2025-02

Locations